New AI security guidelines offers a general overview of expected risks and threats from the initial design process, through the development life cycle and deployment, and all the way through ongoing operation and maintenance after deployment.
The new FDA terms will have manufacturers submit a plan with new applications that demonstrates how they will monitor, identify and address cybersecurity issues, along with "reasonable assurances" that the medical devices are protected from cyber attacks.
